Transforming parasites into their own foes: parasitic extracellular vesicles as a vaccine platform

D Alfandari, S Cadury, MI Morandi… - Trends in …, 2023 - cell.com
Parasitic diseases continue to afflict millions of people globally. However, traditional vaccine
development strategies are often difficult to apply to parasites, leaving an immense unmet …

Yeast cellular stress: impacts on bioethanol production

J Eardley, DJ Timson - Fermentation, 2020 - mdpi.com
Bioethanol is the largest biotechnology product and the most dominant biofuel globally.
Saccharomyces cerevisiae is the most favored microorganism employed for its industrial …

Cheaper faster drug development validated by the repositioning of drugs against neglected tropical diseases

K Williams, E Bilsland, A Sparkes… - Journal of the …, 2015 - royalsocietypublishing.org
There is an urgent need to make drug discovery cheaper and faster. This will enable the
development of treatments for diseases currently neglected for economic reasons, such as …

[HTML][HTML] Plasmodium dihydrofolate reductase is a second enzyme target for the antimalarial action of triclosan

E Bilsland, L Van Vliet, K Williams, J Feltham… - Scientific Reports, 2018 - nature.com
Malaria, caused by parasites of the genus Plasmodium, leads to over half a million deaths
per year, 90% of which are caused by Plasmodium falciparum. P. vivax usually causes …

Genome-wide assessment of the carriers involved in the cellular uptake of drugs: a model system in yeast

K Lanthaler, E Bilsland, PD Dobson, HJ Moss, P Pir… - BMC biology, 2011 - Springer
Background The uptake of drugs into cells has traditionally been considered to be
predominantly via passive diffusion through the bilayer portion of the cell membrane. The …

Pyrimidine metabolism in schistosomes: A comparison with other parasites and the search for potential chemotherapeutic targets

MH El Kouni - Comparative Biochemistry and Physiology Part B …, 2017 - Elsevier
Schistosomes are responsible for the parasitic disease schistosomiasis, an acute and
chronic parasitic ailment that affects> 240 million people in 70 countries worldwide. It is the …

Identification and deconvolution of cross-resistance signals from antimalarial compounds using multidrug-resistant Plasmodium falciparum strains

M Chugh, C Scheurer, S Sax, E Bilsland… - Antimicrobial agents …, 2015 - Am Soc Microbiol
Plasmodium falciparum, the most deadly agent of malaria, displays a wide variety of
resistance mechanisms in the field. The ability of antimalarial compounds in development to …

Metabolic enzymes of helminth parasites: potential as drug targets

D J. Timson - Current Protein and Peptide Science, 2016 - benthamdirect.com
Metabolic pathways that extract energy from carbon compounds are essential for an
organism's survival. Therefore, inhibition of enzymes in these pathways represents a …

Deep mutational scanning of Pneumocystis jirovecii dihydrofolate reductase reveals allosteric mechanism of resistance to an antifolate

FD Rouleau, AK Dubé, I Gagnon-Arsenault… - Plos …, 2024 - journals.plos.org
Pneumocystis jirovecii is a fungal pathogen that causes pneumocystis pneumonia, a
disease that mainly affects immunocompromised individuals. This fungus has historically …

Yeast-Based High-Throughput Screens to Identify Novel Compounds Active against Brugia malayi

E Bilsland, DM Bean, E Devaney… - PLoS neglected tropical …, 2016 - journals.plos.org
Background Lymphatic filariasis is caused by the parasitic worms Wuchereria bancrofti,
Brugia malayi or B. timori, which are transmitted via the bites from infected mosquitoes. Once …